Patents

US 12655138 B2: Process for making an isoxazoline compound and intermediate thereof

Granted
2026-06-16
Filed
2021-07-22 application 18006277
Type
Utility · 19 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present disclosure provides processes for making enantiomerically pure isoxazoline compounds of formula (1), The present disclosure also provides processes for making enantiomerically pure isoxazoline compounds of formula (1) characterized by improving the enantiomeric purity of 3-methyl-5-[(5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]thiophene-2-carboxylic acid by crystallization.

Source: PTBLXML, file of 2026-06-16 (ipgb20260616.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Elanco US Inc. 52 patentsUS company or organizationGreenfield, INPTBLXML, file of 2026-06-16

Inventors

InventorPlacePatentsPerson pageSource
Jean Marie DefauwGreenfield, IN9PTBLXML, file of 2026-06-16
Guanmin WuGreenfield, IN2PTBLXML, file of 2026-06-16
Jingdan HuGreenfield, IN6PTBLXML, file of 2026-06-16
Jing ChenGreenfield, IN19PTBLXML, file of 2026-06-16
Xin ZhangGreenfield, IN22PTBLXML, file of 2026-06-16
Ping HuangGreenfield, IN4PTBLXML, file of 2026-06-16

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D413/04PTBLXML, file of 2026-06-16

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-04-29Correction
Corrective assignment to correct the assignee from sta pharmaceutical r&d co., ltd. to shanghai sta pharmaceutical r&d co., ltd. previously recorded under reel and frame 067108/0934 previously recorded on reel 67108 frame 934. assignor(s) hereby confirms the assignment.
CHEN, JING signed 2021-09-08
ZHANG, XIN signed 2021-09-08
HUANG, PING signed 2021-09-08
SHANGHAI STA PHARMACEUTICAL R&D CO., LTD. SHANGHAI67248/415PASDL, file of 2026-10-15
2024-04-29Correction
Corrective assignment to correct theshangai sta pharmaceutical r&d co.,ltd. to shanghai sta pharmaceutical r&d co.,ltd. previously recorded under reel and frame 067108/0956. assignor(s) hereby confirms the assignment.
SHANGHAI STA PHARMACEUTICAL R&D CO., LTD. signed 2021-09-08STA PHARMACEUTICAL HONG KONG LIMITED WANCHAI67248/15PASDL, file of 2026-10-15
2024-04-15Assignment
Assignment of assignor's interest
STA PHARMACEUTICAL HONG KONG LIMITED signed 2021-09-18ELANCO US INC. GREENFIELD, IN67108/959PASDL, file of 2026-10-15
2024-04-15Assignment
Assignment of assignor's interest
SHANGAI STA PHARMACEUTICAL R&D CO., LTD. signed 2021-09-08STA PHARMACEUTICAL HONG KONG LIMITED WANCHAI67108/956PASDL, file of 2026-10-15
2024-04-15Assignment
Assignment of assignor's interest
CHEN, JING signed 2021-09-08
ZHANG, XIN signed 2021-09-08
HUANG, PING signed 2021-09-08
STA PHARMACEUTICAL R&D CO., LTD. SHANGHAI67108/934PASDL, file of 2026-10-15
2024-04-15Assignment
Assignment of assignor's interest
DEFAUW, JEAN MARIE signed 2021-08-23
HU, JINGDAN signed 2021-08-19
WU, GUANMIN signed 2021-08-19
ELANCO US INC. GREENFIELD, IN67108/926PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.